当前位置: 首页 > 期刊 > 《河北医学》 > 2006年第8期
编号:11155400
波依定在高血压治疗中的达标率观察
http://www.100md.com 《河北医学杂志》 2006年第8期
波依定;,高血压;,达标率,,波依定;,高血压;,达标率,1资料和方法,2结果,3讨论,参考文献:
     摘要:目的:观察波依定在高血压治疗中的达标率。方法:选取60例高血压患者,给予波依定5~10mg/d,疗程10周。结果:血压平均从(166.2±14.9)/(99.5±11.2)mmHg降到(132.4±8.8)/(78.4±7.2)mmHg,10周降压达标率达85.0%,治疗过程中未发现任何严重不良反应。结论:波依定治疗原发性高血压,具有高效、安全、病人依从性好的优点。

    关键词: 波依定; 高血压; 达标率

    O bserving the control rates of Felodipine sustained Release tablets in Hypertension

    ZHOU Li

    (The Second People's Hospital of Anqing, Anhui Anqing 246003, China)

    Abstract:Objective:To observe the control rates for blood pressure of felodipine sustained release tablets in Chinese hypertensive patients. Method: 60 cases were recruited, the patients were administered 5mg~10mg/day for 10 weeks. Result: Mean blood pressure were found to be significantly lowered from166.2±14.9/99.5±11.2mmHg to 132.4±8.8/78.4±7.2mmHg.The control rates for blood pressure at the 10th week were 85.0%. No serious side effect was found during the course of the treatment.Conclusion: Felodipine sustained release tablets 5mg~10mg/day is effective, safe and better compliance in Chinese patients with primary hypertension. ......

您现在查看是摘要页,全文长 4376 字符